Sanguibiotech AG
58455 WITTEN GERMANY, DE· latest recorded location
Sanguibiotech AG is named on 4 US grants and 3 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 4
- Published applications
- 3
- Inventors
- 10
- Granted in 2026 so far
- 0
- Most recent grant
- 28 Feb 2006
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 1 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
By publication year.
Technology areas
Share of 7 documents
- C07KPeptides5
- A61KMedicines and medical preparations3
- C08HDerivatives of natural macromolecular compounds2
- A61LMethods or apparatus for sterilising materials or objects in general1
- A61PTherapeutic uses of medicines1
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1
Recent patents
- Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof28 Feb 2006US 7,005,414 B2
- Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof18 Oct 2005US 6,956,025 B2
- Method for obtaining uniform fractions of hyperpolymeric hemoglobins30 Nov 1999US 5,994,509 A
- Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof16 Nov 1999US 5,985,332 A
- Therapeutically active dressings, their manufacture and use28 Jun 2007US 2007/0148215 A1
- Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof12 Feb 2004US 2004/0029780 A1
- Mammalion haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof22 Jan 2004US 2004/0014641 A1
Most cited
By later US patents
- Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof36US 7,005,414 B22006
- Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof14US 5,985,332 A1999
- Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof6US 6,956,025 B22005
- Method for obtaining uniform fractions of hyperpolymeric hemoglobins2US 5,994,509 A1999